Connect Biopharma Holdings Ltd(CNTB)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Connect Biopharma Holdings Ltd (CNTB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CNTB at 27.6/100 on a 32-signal composite quality model, placing it at rank #2,575 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Connect Biopharma Holdings Ltd reports quarterly revenue of $2.8M, net income of $-17.3M, free cash flow of $-15.9M. Top institutional holders of CNTB by reported 13-F value include Ikarian Capital, 683 Capital Management, BOOTHBAY FUND MANAGEMENT, based on the most recent SEC filings. CNTB trades on the Nasdaq exchange and files with the SEC under CIK 1835268. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CNTB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Connect Biopharma Holdings Ltd directly from SEC EDGAR.